GILEAD SCIENCES INC Insider Trading for February 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GILEAD SCIENCES INC for February 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27 2017 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | M | 20.71 | 33,350 | 690,512 | 0 | |
| Feb 27 2017 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Sell | S | 69.30 | 20,365 | 1,411,374 | 120,471 | 140.8 K to 120.5 K (-14.46 %) |
| Feb 27 2017 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Buy | M | 20.71 | 33,350 | 690,512 | 140,836 | 107.5 K to 140.8 K (+31.03 %) |
| Feb 27 2017 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | M | 21.58 | 100,000 | 2,157,500 | 220,000 | |
| Feb 27 2017 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Buy | M | 21.58 | 100,000 | 2,157,500 | 1,165,924 | 1.1 M to 1.2 M (+9.38 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Payment of Exercise | F | 70.31 | 7,814 | 549,402 | 21,406 | 29.2 K to 21.4 K (-26.74 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Grant | A | 0.00 | 3,185 | 0 | 29,220 | 26 K to 29.2 K (+12.23 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Grant | A | 0.00 | 4,516 | 0 | 26,035 | 21.5 K to 26 K (+20.99 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Grant | A | 59.33 | 315 | 18,689 | 21,519 | 21.2 K to 21.5 K (+1.49 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Payment of Exercise | F | 70.31 | 8,389 | 589,831 | 1,065,924 | 1.1 M to 1.1 M (-0.78 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Grant | A | 0.00 | 3,429 | 0 | 1,074,313 | 1.1 M to 1.1 M (+0.32 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Grant | A | 0.00 | 11,606 | 0 | 1,070,884 | 1.1 M to 1.1 M (+1.10 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Grant | A | 59.33 | 315 | 18,689 | 1,059,278 | 1.1 M to 1.1 M (+0.03 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Gift | G | 0.00 | 4,354 | 0 | 125,505 | 121.2 K to 125.5 K (+3.59 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Gift | G | 0.00 | 4,354 | 0 | 2,715 | 7.1 K to 2.7 K (-61.59 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Payment of Exercise | F | 70.31 | 2,053 | 144,346 | 7,069 | 9.1 K to 7.1 K (-22.51 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Grant | A | 0.00 | 1,022 | 0 | 9,122 | 8.1 K to 9.1 K (+12.62 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Grant | A | 0.00 | 1,161 | 0 | 8,100 | 6.9 K to 8.1 K (+16.73 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Grant | A | 59.33 | 213 | 12,637 | 6,939 | 6.7 K to 6.9 K (+3.17 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | A | 70.31 | 123,210 | 8,662,895 | 123,210 | |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Payment of Exercise | F | 70.31 | 25,271 | 1,776,804 | 3,126,636 | 3.2 M to 3.1 M (-0.80 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Grant | A | 0.00 | 8,572 | 0 | 3,151,907 | 3.1 M to 3.2 M (+0.27 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Grant | A | 0.00 | 11,924 | 0 | 3,143,335 | 3.1 M to 3.1 M (+0.38 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Grant | A | 59.33 | 315 | 18,689 | 3,131,411 | 3.1 M to 3.1 M (+0.01 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Gift | G | 0.00 | 11,558 | 0 | 2,318,407 | 2.3 M to 2.3 M (+0.50 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Gift | G | 0.00 | 11,558 | 0 | 12,453 | 24 K to 12.5 K (-48.14 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Payment of Exercise | F | 70.31 | 7,070 | 497,092 | 24,011 | 31.1 K to 24 K (-22.75 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 0.00 | 3,021 | 0 | 31,081 | 28.1 K to 31.1 K (+10.77 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 0.00 | 5,773 | 0 | 28,060 | 22.3 K to 28.1 K (+25.90 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 59.33 | 315 | 18,689 | 22,287 | 22 K to 22.3 K (+1.43 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Payment of Exercise | F | 70.31 | 6,577 | 462,429 | 124,418 | 131 K to 124.4 K (-5.02 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Grant | A | 0.00 | 2,776 | 0 | 130,995 | 128.2 K to 131 K (+2.17 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Grant | A | 0.00 | 4,940 | 0 | 128,219 | 123.3 K to 128.2 K (+4.01 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Grant | A | 59.33 | 315 | 18,689 | 123,279 | 123 K to 123.3 K (+0.26 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | Chief Operating Off ... | Grant | A | 59.33 | 315 | 18,689 | 2,881 | 2.6 K to 2.9 K (+12.28 %) |
| Feb 14 2017 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | Chief Operating Off ... | Option Exercise | M | 0.00 | 908 | 0 | 5,622 | |
| Feb 14 2017 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | Chief Operating Off ... | Payment of Exercise | F | 66.36 | 317 | 21,036 | 2,566 | 2.9 K to 2.6 K (-11.00 %) |
| Feb 14 2017 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | Chief Operating Off ... | Buy | M | 0.00 | 908 | 0 | 2,883 | 2 K to 2.9 K (+45.97 %) |
| Feb 06 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Option Exercise | A | 72.25 | 90,430 | 6,533,568 | 90,430 | |
| Feb 06 2017 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | A | 72.25 | 325,000 | 23,481,250 | 325,000 | |
| Feb 06 2017 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Option Exercise | A | 72.25 | 101,740 | 7,350,715 | 101,740 | |
| Feb 06 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Option Exercise | A | 72.25 | 42,390 | 3,062,678 | 42,390 | |
| Feb 06 2017 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | A | 72.25 | 104,570 | 7,555,183 | 104,570 | |
| Feb 06 2017 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | Chief Operating Off ... | Option Exercise | A | 72.25 | 115,870 | 8,371,608 | 115,870 | |
| Feb 03 2017 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | Chief Operating Off ... | Option Exercise | M | 0.00 | 620 | 0 | 6,530 | |
| Feb 03 2017 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | Chief Operating Off ... | Payment of Exercise | F | 72.82 | 215 | 15,656 | 1,975 | 2.2 K to 2 K (-9.82 %) |
| Feb 03 2017 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | Chief Operating Off ... | Buy | M | 0.00 | 620 | 0 | 2,190 | 1.6 K to 2.2 K (+39.49 %) |
| Feb 03 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 21.58 | 73,333 | 1,582,159 | 733,330 | |
| Feb 03 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 72.57 | 73,333 | 5,322,069 | 3,131,096 | 3.2 M to 3.1 M (-2.29 %) |
| Feb 03 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 21.58 | 73,333 | 1,582,159 | 3,204,429 | 3.1 M to 3.2 M (+2.34 %) |